NIH Bioanalysis Testing Services

IDIQ

Description

Provide bioanalysis testing services of the government's samples in support of the research conducted at NCATS/NCGC. Specifically, the contractor will perform bioanalysis testing services on the government furnished small molecules and samples and provide a report to the government of the results of the services including the profiling of 60 small molecules against a panel of 94 representative cancer cell lines. The National Center for Advancing Translational Sciences (NCATS) is the newest of 27 Institutes and Centers (ICs) at the National Institutes of Health (NIH).

Overview

Ceiling

$20,000,000

Primary Sponsoring Agency

National Institute on Drug Abuse (NIDA) [HHS - NIH]

Who Can Use

One Agency

Primary NAICS

541380 - Testing Laboratories and Services

Primary PSC

Q301 - Reference Laboratory Testing

Primary Set Aside

None

Extent Competed

Full And Open Competition

NIH Bioanalysis Testing Services awarded by National Institute on Drug Abuse (NIDA) in September 2015 accepts orders through September 2020. The IDIQ has a reported ceiling of $20,000,000, and as of today, $3,842,360 has been obligated through the vehicle. The IDIQ was awarded full & open and has a primary NAICS code of 541380.

Award Hierarchy

Vehicle

NIH Bioanalysis Testing Services

Indefinite Delivery Vehicles

Prime Contracts

Subcontracts

Status

Period of Performance

9/15/15

Start Date

9/14/20

Ordering Period End Date

100% Complete

Task Order Obligations

$3.8M

Total Obligated

$3.8M

Current Award

$3.8M

Potential Award

100% Funded

Vehicle Award Share

Contractors with greatest percentage of obligations for NIH Bioanalysis Testing Services

Vehicle Award Share

Federal Award Analysis